Akigin Capital Partners

Akigin Capital Partners is a Japanese private equity firm specializing in investments in small and medium-sized enterprises (SMEs). The firm is a subsidiary of Akita Bank, reflecting its strong ties to the local financial sector. Akigin Capital Partners is headquartered in Tokyo, Japan, with its office located on the 5th floor of Akita Bank's Main Branch in Akita City. The firm's official website is https://akigin-c-p.co.jp.

The firm's investment strategy encompasses various stages, including Seed, Series A, Series B, and Growth phases. Akigin Capital Partners primarily focuses on sectors such as Healthcare, Health Diagnostics, and Medical industries. The firm has a geographical focus on Japan, aligning with its commitment to supporting domestic SMEs.

Akigin Capital Partners has demonstrated active investment activity, with a notable investment in Cranebio, a company specializing in Health Care, Health Diagnostics, and Medical sectors, in October 2023. The firm typically invests around $2 million per deal, indicating a preference for early-stage ventures. This approach underscores Akigin Capital Partners' dedication to fostering growth and innovation within Japan's SME landscape.